Earnings History Data for KALA BIO, Inc. (KALA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

KALA BIO, Inc.

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. The Company designs proprietary drug delivery technology to penetrate mucosal tissue such as the eyes, lungs, gastrointestinal tracts and the female reproductive systems. Kala Pharmaceuticals, Inc. is based in Waltham, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	PM		KALA	KALA BIO, Inc.	31.65	-1.93	-2.43	-3.41	KALA BIO GAAP EPS of -$1.93 beats by $0.50 [11/12/2024 8:47 AM]	7.13	-0.27 (-3.58%)	7.53	-0.10 (-1.31%)	4.21 - 10.97	19,914	40,000	311
KALA BIO GAAP EPS of -$1.93 beats by $0.50 [11/12/2024 8:47 AM] KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update [2024-11-12 08:00AM]
06-08-2024	PM		KALA	KALA BIO, Inc.	27.00	-3.16	-4.41	0.00	KALA BIO GAAP EPS of -$3.16 [8/6/2024 9:19 AM]	6.19	0.24 (4.03%)	0.0	0.0 (0.00%)	4.21 - 14.50	17,309	30,000	0
KALA BIO GAAP EPS of -$3.16 [8/6/2024 9:19 AM]
13-11-2023	PM		KALA	KALA BIO, Inc.	15.00	-3.41	-2.15	0.00	Kala Pharmaceuticals GAAP EPS of -$3.41 misses by $1.26 [11/13/2023 2:34 PM]	5.28	-0.29 (-5.30%)	5.51	-0.06 (-1.08%)	3.54 - 56.72	8,530	10,000	2,096
Kala Pharmaceuticals GAAP EPS of -$3.41 misses by $1.26 [11/13/2023 2:34 PM]
04-08-2023	PM		KALA	KALA BIO INC	36.00	-4.36	-3.19	0.00	Kala Pharmaceuticals GAAP EPS of -$4.36 [8/4/2023 12:28 PM]	14.09	-0.26 (-1.81%)	0.0	0.0 (0.00%)	3.54 - 56.72	37,183	40,000	0
Kala Pharmaceuticals GAAP EPS of -$4.36 [8/4/2023 12:28 PM]
09-05-2023	PM		KALA	Kala Pharmaceuticals	31.00	-6.99	-5.10	0.00		15.45	-0.36 (-2.25%)	0.0	0.0 (0.00%)	3.54 - 56.72	59,321	100,000	0

03-03-2023	PM		KALA	Kala Pharmaceuticals	16.00	-7.97	-6.56	0.00	Kala Pharmaceuticals GAAP EPS of -$7.97 misses by $1.42 [3/3/2023 8:17 AM]	16.82	6.65 (65.37%)	10.61	0.44 (4.35%)	3.54 - 97.00	6,568,723	170,000	1,980
Kala Pharmaceuticals GAAP EPS of -$7.97 misses by $1.42 [3/3/2023 8:17 AM]
08-11-2022	PM		KALA	Kala Pharmaceuticals	8.00	19.25	10.75	0.00	Kala Pharmaceuticals GAAP EPS of $19.25, revenue of $0.42M [11/8/2022 8:56 AM]	5.22	0.04 (0.77%)	5.20	0.02 (0.39%)	4.92 - 114.00	28,693	30,000	462
Kala Pharmaceuticals GAAP EPS of $19.25, revenue of $0.42M [11/8/2022 8:56 AM] Kala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-08-22 08:00AM]
11-08-2022	PM	7:00 AM ET (Aug 11)	KALA	Kala Pharmaceuticals, Inc.	18.76	-0.38	-0.44	-0.57	Kala Pharmaceuticals GAAP EPS of -$0.38, revenue of $2.1M [8/11/2022 7:06 AM]	0.3249	-0.02 (-6.64%)	0.40	0.05 (15.14%)	0.28 - 3.61	5,471,932	540,000	2,708,133
Kala Pharmaceuticals Q2 2022 Earnings Preview [8/10/2022 1:52 PM] Kala Pharmaceuticals GAAP EPS of -$0.38, revenue of $2.1M [8/11/2022 7:06 AM] Kala Pharma sees large fall in operating expenses for H2, FY, extends expected cash runway [8/11/2022 9:51 AM] Kala Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update [Aug-11-22 07:00AM]
16-05-2022	PM	7:00 AM ET (May 16)	KALA	Kala Pharmaceuticals, Inc.	35.00	-0.45	-0.36	-0.49	Kala Pharmaceuticals GAAP EPS of -$0.45 misses by $0.11, revenue of $1.37M misses by $1.51M [5/16/2022 7:03 AM]	0.7332	0.05 (7.26%)	0.65	-0.03 (-4.92%)	0.59 - 6.77	707,773	960,000	5,755
Kala Pharmaceuticals GAAP EPS of -$0.45 misses by $0.11, revenue of $1.37M misses by $1.51M [5/16/2022 7:03 AM] Kala stock rises despite Q1 earnings miss [5/16/2022 11:38 AM] Kala Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-16-22 07:00AM] Kala Pharmaceuticals (KALA) Reports Q1 Loss, Misses Revenue Estimates [May-16-22 08:15AM]
29-03-2022	PM		KALA	Kala Pharmaceuticals, Inc.	103.15	-0.68	-0.43	-0.55	Kala Pharmaceuticals GAAP EPS of -$0.68 misses by $0.29, revenue of $1.87M misses by $1.55M [3/29/2022 7:04 AM]	1.51	-0.24 (-13.71%)	1.52	-0.23 (-13.14%)	0.59 - 8.38	2,479,187	1,930,000	221,766
Kala Pharmaceuticals GAAP EPS of -$0.68 misses by $0.29, revenue of $1.87M misses by $1.55M [3/29/2022 7:04 AM] Kala Pharmaceuticals stock falls 13% as Q4 net loss widens, revenue declines Y/Y [3/29/2022 12:07 PM] Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update [Mar-29-22 07:00AM] Kala Pharmaceuticals (KALA) Reports Q4 Loss, Lags Revenue Estimates [Mar-29-22 08:15AM]
15-11-2021	PM	7:00 AM ET (Nov 15)	KALA	Kala Pharmaceuticals, Inc.	117.17	-0.43	-0.45	-0.50	Kala Pharmaceuticals EPS in-line, misses on revenue [11/15/2021 8:50 AM]	2.10	0.03 (1.40%)	2.02	-0.05 (-2.42%)	1.69 - 9.97	2,314,347	1,800,000	44,836
Kala Pharmaceuticals EPS in-line, misses on revenue [11/15/2021 8:50 AM] Kala Pharma acquires Combangio gaining corneal defect candidate [11/15/2021 12:53 PM] Kala Pharmaceuticals Announces Time Change for Third Quarter 2021 Financial Results Conference Call [Nov-15-21 07:00AM] Kala Pharmaceuticals Acquires Combangio, Expanding its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED) and other Rare Ocular Surface Diseases [Nov-15-21 08:45AM] Kala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-15-21 08:47AM] Kala Pharmaceuticals (KALA) Reports Q3 Loss, Misses Revenue Estimates [Nov-15-21 12:25PM] Kala Pharma Acquires Ocular Surface Disease-Focused Company [Nov-15-21 03:15PM]
05-08-2021	PM	7:00 AM ET (Aug 5)	KALA	Kala Pharmaceuticals, Inc.	193.41	-0.57	-0.46	-0.42	Kala Pharmaceuticals EPS misses by $0.13, misses on revenue [8/5/2021 7:02 AM]	3.16	-0.19 (-5.67%)	2.87	-0.48 (-14.33%)	2.75 - 9.97	3,796,965	1,230,000	260,724
Kala Pharmaceuticals EPS misses by $0.13, misses on revenue [8/5/2021 7:02 AM] Kala Pharmaceuticals to Present at Upcoming Investor Conferences in August [Aug-04-21 08:00AM] Kala Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-05-21 07:00AM]
05-05-2021	PM	7:00 AM ET (May 5)	KALA	Kala Pharmaceuticals, Inc.	433.34	-0.49	-0.51	-0.54	Kala Pharmaceuticals EPS misses by $0.01, misses on revenue [5/5/2021 7:03 AM]	5.95	-0.50 (-7.75%)	6.40	-0.05 (-0.78%)	5.92 - 14.68	3,885,765	2,060,000	83,840
Kala Pharmaceuticals EPS misses by $0.01, misses on revenue [5/5/2021 7:03 AM] Kala Pharmaceuticals, Inc. to Host Earnings Call [May-05-21 06:15AM] Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-05-21 07:01AM] Kala Pharmaceuticals (KALA) Reports Q1 Loss, Misses Revenue Estimates [May-05-21 08:15AM]
25-02-2021	PM	7:00 AM ET (Feb 25)	KALA	Kala Pharmaceuticals, Inc.	505.10	-0.55	-0.46	-0.63	Kala Pharmaceuticals EPS misses by $0.09, misses on revenue [2/25/2021 7:08 AM]	7.75	-1.18 (-13.21%)	9.05	0.12 (1.34%)	5.04 - 14.68	4,780,010	2,267,869	115,665
Kala Pharmaceuticals EPS misses by $0.09, misses on revenue [2/25/2021 7:08 AM] Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update [Feb-25-21 07:00AM] Kala Pharmaceuticals, Inc. to Host Earnings Call [Feb-25-21 06:15AM]
05-11-2020	PM	7:00 AM ET (Nov 5)	KALA	Kala Pharmaceuticals, Inc.	409.24	-0.50	-0.44	-0.68	Kala Pharmaceuticals EPS misses by $0.06, beats on revenue [11/5/2020 7:09 AM]	7.26	0.01 (0.14%)	7.26	0.0 (0.00%)	3.45 - 14.68	1,481,558	2,514,482	12,592

06-08-2020	PM	7:00 AM ET (Aug 6)	KALA	Kala Pharmaceuticals, Inc.	516.49	-0.42	-0.42	-0.70	Kala Pharmaceuticals EPS misses by $0.01, beats on revenue [8/6/2020 7:08 AM]	9.24	0.07 (0.76%)	9.20	0.03 (0.33%)	3.24 - 14.68	452,465	905,831	87,109